- All sections
- C - Chemistrymetallurgy
- C12Q - Measuring or testing processes involving enzymes, nucleic acids or microorganismscompositions or test papers thereforprocesses of preparing such compositionscondition-responsive control in microbiological or enzymological processes
- C12Q 1/6886 - Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
Patent holdings for IPC class C12Q 1/6886
Total number of patents in this class: 11543
10-year publication summary
|
345
|
419
|
858
|
1248
|
1349
|
1297
|
1391
|
1456
|
1311
|
512
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Immatics Biotechnologies GmbH | 1152 |
299 |
| The Regents of the University of California | 19784 |
177 |
| Dana-Farber Cancer Institute, Inc. | 2545 |
167 |
| The Johns Hopkins University | 5628 |
160 |
| Guardant Health, Inc. | 406 |
143 |
| Mayo Foundation for Medical Education and Research | 3174 |
134 |
| The General Hospital Corporation | 4700 |
129 |
| Foundation Medicine, Inc. | 340 |
120 |
| Inserm (institut National de La Sante et de La Recherche Medicale) | 3358 |
112 |
| The Board of Trustees of the Leland Stanford Junior University | 6329 |
110 |
| Memorial Sloan-Kettering Cancer Center | 1901 |
108 |
| Board of Regents, The University of Texas System | 5738 |
98 |
| Exact Sciences Corporation | 296 |
92 |
| The Broad Institute, Inc. | 1772 |
86 |
| National Cancer Center | 407 |
84 |
| Institut National de La Sante et de La Recherche Medicale (inserm) | 2735 |
82 |
| Genentech, Inc. | 3935 |
79 |
| Grail, Inc. | 198 |
72 |
| Centre National de La Recherche Scientifique | 10284 |
71 |
| Toray Industries, Inc. | 6867 |
69 |
| Other owners | 9151 |